Patrick Bruce Johnston, MD, PhD

  • 5771 Citations
  • 43 Scopus h-Index
1993 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Patrick Bruce Johnston is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 47 Similar Profiles
Lymphoma Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Non-Hodgkin's Lymphoma Medicine & Life Sciences
Survival Medicine & Life Sciences
Hodgkin Disease Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Lymphocyte Count Medicine & Life Sciences
Stem Cell Transplantation Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1993 2019

  • 5771 Citations
  • 43 Scopus h-Index
  • 117 Article
  • 3 Review article
  • 1 Chapter
  • 1 Comment/debate

Autograft immune content and survival in non-Hodgkin's lymphoma: A post hoc analysis

Porrata, L. F., Inwards, D. J., Ansell, S. M., Micallef, I., Johnston, P. B., Villasboas Bisneto, J. J. C. . & Markovic, S. N., Jun 1 2019, In : Leukemia Research. 81, p. 1-9 9 p.

Research output: Contribution to journalArticle

Autografts
Peripheral Blood Stem Cell Transplantation
Hematopoietic Stem Cell Transplantation
Non-Hodgkin's Lymphoma
Survival
3 Citations (Scopus)

Late relapses in patients with diffuse large b-cell lymphoma treated with immunochemotherapy

Wang, Y., Farooq, U., Link, B. K., Larson, M. C., King, R., Maurer, M. J., Allmer, C., Hefazi, M., Thompson, C. A., Micallef, I., Johnston, P. B., Habermann, T. M., Witzig, T. E., Ansell, S. M., Cerhan, J. R. & Nowakowski, G. S., Jul 20 2019, In : Journal of Clinical Oncology. 37, 21, p. 1819-1827 9 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Lymphoma
Recurrence
Germinal Center
B-Lymphocytes

Persistent mediastinal FDG uptake on PET-CT after frontline therapy for Hodgkin lymphoma: biopsy, treat or observe?

Novo, M., Nowakowski, G. S., Habermann, T. M., Witzig, T. E., Micallef, I. N., Johnston, P. B., Inwards, D. J., Botto, B., Ristow, K. M., Young, J. R., Vitolo, U. & Ansell, S. M., Jan 1 2019, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Hodgkin Disease
Biopsy
Salvage Therapy
Therapeutics
Positron Emission Tomography Computed Tomography
7 Citations (Scopus)

Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL

Tam, C. S., Trotman, J., Opat, S., Burger, J. A., Cull, G., Gottlieb, D., Harrup, R., Johnston, P. B., Marlton, P., Munoz, J., Seymour, J. F., Simpson, D., Tedeschi, A., Elstrom, R., Yu, Y., Tang, Z., Han, L., Huang, J., Novotny, W., Wang, L. & 1 others, Roberts, A. W., Sep 12 2019, In : Blood. 134, 11, p. 851-859 9 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Toxicity
B-Lymphocytes
Cells
Safety

A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma

Padrnos, L., Ernst, B., Dueck, A., Kosiorek, H. E., Ginos, B. F., Toro, A., Johnston, P. B., Habermann, T. M., Leis, J. F., Mikhael, J. R., Nowakowski, G. S., Colgan, J., Porrata, L., Ansell, S. M., Witzig, T. E. & Reeder, C., Jan 1 2018, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Lymphoma
Pharmaceutical Preparations
Maximum Tolerated Dose
Neutropenia
Hodgkin Disease